ESP banner

11th Annual Land O’Lakes Bioanalytical Conference
A New Decade of Bioanalysis of Large and Small Molecules
July 19-23, 2010
Devil’s Head Resort
Merrimac, WI

Developed & Conducted by Extension Services in Pharmacy, School of Pharmacy, University of Wisconsin-Madison.

POSTER SESSION

Guidelines for Poster Submissions

Poster session



Previous Posters Accepted

Special Offer for Academic Institutions

Extension Services in Pharmacy at the University of Wisconsin School of Pharmacy has instituted a new policy for industrial professional development programs to encourage greater participation by faculty, graduate students and post doctoral students at academic institutions. Programs will be offered at a significantly reduced price, based on space availability. For information about any specific course please contact Dr. James E. De Muth by email.

Global Conference Goals & Objectives

The purpose of this four-day conference is to provide an educational forum to discuss issues and applications associated with the analysis of xenobiotics, their metabolites and endogenous biomarkers in biological matrices. The conference is designed to include and encourage an open exchange of scientific and methodological applications for bioanalysis. To increase the interactive nature of the conference, the program will be a mixture of lecture, discussion groups and workshops. Goals associated with this conference include:

  1. To provide a better understanding of the bioanalysis of large and small molecule xenobiotics, biomarkers and immunogenicity in biological matrices;
  2. To evaluate new technology and share experiences;
  3. To gain insight into problems and issues encountered during the drug discovery process and the interface between drug discovery and development;
  4. To discuss current global regulatory issues affecting bioanalysis;
  5. To identify processes for improving the identification and quantification of successful drug candidates and their measurement, including in vitro/in vivo implications;
  6. To discuss analytical issues relating to drug metabolism and pharmacokinetics and their applicability in drug development activity;
  7. To discuss issues associated with information management, data handling and automation in bioanalytical laboratories;
  8. To gain insight into various perspectives on the drug development process, including industry, academia and regulatory agencies; and
  9. To evaluate the harmonization of methods validation, quality control and set standards for drug metabolite identification in studies involving bioanalysis.

Evaluation results from 2009 Conference

Slides generated from Workshop dealing with daily lab problems

Round Table Minutes 2009 Incurred Sample Analysis

2009 Conference Travel Information

Location & Travel

The conference will be presented at Devil's Head Resort in Merrimac, Wisconsin. Merrimac is approximately 40 minutes from Madison. For those registrants flying into Madison, bus transportation will be available to and from Devil's Head Resort.

Shuttle Bus Service to and from the Dane County Regional Airport

Monday 1:30 and 4:30 PM

Friday 10:45 AM

Sponsored by:

Cetero Research,
Cary, NC

2010 Conference fees

Registration Fee

$1250.00

Lodging & Meals: Single Accommodations

$625.00

Total Amount

$1,875.00

If Payment received prior to June 21, 2010

-$150.00

EARLY REGISTRATION

$1,725.00

NOTE: All accommodations at Devil's Head for conference registrants will be processed through Extension Services in Pharmacy. Fees are based on a single accommodation. Additional fees will be assessed for both lodging in the event more than one person occupies a room.

Enrollment Deadlines/Limits

A check in the total amount payable to UNIVERSITY OF WISCONSIN should accompany your application to ensure that space will be held for you. Credit card payment is also acceptable. Total payment will be returned /refunded if space is not available.

In the event your registration is confirmed and at a later date you are unable to personally attend, a refund (less a $50 administrative fee) will be provided prior to June 21; after June 21, no refunds will be made. You may fax your registration (608) 262-2431 with payment to follow no later than June 21. After June 21, space will not be held without receipt of payment.

Conference Support for 2010

Speical thanks for unrestricted educational grant to help support this conference from

Enthalpy Analytical, Inc.
Durham, NC

PPD, Inc.
Richmond, VA

Covance Laboratories
Madison, WI

Covance logo

York Bioanalytical Solutions
Upper Poppleton, York, United Kingdom

Meeting Room      Meeting Room

2009 Program Outline (2010 Program is currently being developed)

Monday, July 13

 

6:00pm

Opening Reception

Sponsored by:

MDS Pharma Services
Lincoln, NE

7:00pm

Dinner

Welcomes from Conference Chair & Coordinator

Tuesday, July 14

First Plenary Session: New Technologies with Analytical Applications

Moderator:

Mark Arnold, Ph.D.
Group Director, Bioanalytical Sciences Department
Bristol-Myers Squibb Company, New Brunswick, NJ

8:00am

Welcome and Overview

8:15am

Microfluidics and Immunoassay Applications for Large Molecules

Michael McKenna
Chief Scientific Officer
Tethys Biosciences Inc.
Emeryville, CA

9:05am

Biomarker Large Molecule Conversion to LC-MS/MS

Richard Jones, Ph.D.
Head, Mass Spectrometry
NextGen Sciences, Inc., Ann Arbor, MI

9:55am

Break

10:20am

Ion Transmission to Improve Sensitivity of MS

Keqi Tang, Ph.D.
Staff Scientis, Biological Sciences Division
Pacific Northwest National Laboratory, Richland, WA

11:10am

Detecting, Identifying and Quantifying Metabolites from First-in-Human Studies: Role of Orbitrap MS

Swapan Chowdhury, Ph.D.
Director, Drug Disposition
Schering Plough Research Institute, Kenilworth, NJ

12:00pm

Lunch

1:00pm

Afternoon Session –Identifying Metabolites Using Alternative Approaches and Complying with MIST Guidance

Moderator:

Eric N. Fluhler, Ph.D.
Assistant Vice President, Bioanalytical R&D
Drug Safety and Metabolism, Wyeth Research, Pearl River, NY

1:00

Obtaining Exposures of Metabolites in Preclinical Species Through Plasma Pooling and Quantitative NMR

Abdul Mutlib, Ph.D.
Director, Mass Spectrometry, Drug Safety and Metabolism
Wyeth Research, Collegeville, PA

1:25

Bioanalytical Techniques with a TWIST to support MIST

Ragu Ramanathan, Ph.D
Associate Director, Biotransformation
Bristol Myers Squibb, Princeton, NJ

1:50

Analytical Strategies for Post-MIST Clarity

David S. Wagner, Ph.D.
Investigator, US DMPK
GlaxoSmithKline, Research Triangle Park, NC

2:15

Panel Discussion

Abdul Mutlib, Ph.D.
Ragu Ramanathan, Ph.D
David S. Wagner, Ph.D.

2:45pm

Boat tour of the Wisconsin Dells

Sponsor:

PharmaNet Development Group
Princeton, NJ

6:30pm

Dinner

 

Evening Session

Moderator:

Thomas G. Huggins, Ph.D.
Senior Staff Scientist, Bioanalytical
Procter and Gamble Pharmaceuticals, Mason, OH

8:00pm

Transfer, Development and Validation of Cell-based Neutralizing Antibodies (NAb) Assays

Pierre Jolicoeur, Ph.D.
Associate Director, ICD
PPD Development, Richmond, VA

9:00pm

Dessert Reception

Sponsor:

Tandem Labs
Salt Lake City, UT

Wednesday, July 15

Second Plenary Session –Bioanalytical Sample Preparation

Moderator:

Michael J. Hayes, Ph.D.
Translational Sciences
Drug Metabolism & Pharmacokinetics Department
Novartis Institutes for BioMedical Research, East Hanover, NJ

8:00am

Comparison of Technologies for Phospholipid Removal

Russell P. Grant, Ph.D.
Strategic Director NOQS
LabCorp, Burlington, NC

8:50am

Derivatization

Alan L. Rockwood, PhD
Scientific Director for Mass Spectrometry, ARUP Laboratories
Associate Professor of Pathology (Clinical), University of Utah
Salt Lake City, UT

9:40am

Break

10:20am

The Use of Dried Blood Spot Samples for the Quantitative Bioanalysis of Drugs in PreClinical and Clinical Studies

Neil Spooner, Ph.D.
Director, Bioanalytical Sciences & Development Europe
PCD DMPK, GlaxoSmithKline, Hertfordshire, United Kingdom

11:10am

Mass Spectrometry-based Enzyme Assays for High Throughput, Label-free Screening

Kenneth D. Greis, Ph.D.
Associate Professor of Cancer & Cell Biology
Director, Proteomics & Mass Spectrometry
Genome Research Institute, University of Cincinnati, Cincinnati, OH

12:00pm

Lunch

1:00pm

Two Parallel Short Courses (two hours each)

Immunochemistry 101

Moderator:

Russell P. Grant, Ph.D.
Strategic Director NOQS
LabCorp, Burlington, NC

Lakshmi Amaravadi, Ph.D.
Associate Director
Preclinical & Clinical Development Sciences
BiogenIdec, Cambridge, MA


Primer on the Fundamentals of LCMS

Moderator:

Robert P. Clement, Ph.D.
Senior Director, Bioanalytical and Toxicokinetics
Schering-Plough Research Institute, Lafayette, NJ

Roger N. Hayes, Ph.D.
Director, Bioanalytical, Bioanalytical & Toxicokinetics
Schering-Plough Research Institute, Lafayette, NJ

Shane Needham, Ph.D.
Laboratory Director
Alturas Analytics, Inc., Moscow, ID

5:00pm

Poster Session

Wine and Cheese Reception

Sponsor:

CEDRA Corporation
Austin, TX

6:30pm

Dinner

8:00pm

Evening Round Table Discussions

  1. Strategies to Enhance Sensitivity in MS Assays
    Russell P. Grant, Ph.D.
    Strategic Director NOQS
    LabCorp, Burlington, NC
  2. Incurred Sample Reanalysis Investigation
    Min Chang, Ph.D.
    Principal Scientist, Bioanalytical
    Biogen Idec, San Diego, CA
  3. Factors that Gate the Bioanalytical Work Process
    Thomas G. Huggins, Ph.D.
    Senior Staff Scientist, Bioanalytical
    Procter and Gamble Pharmaceuticals, Mason, OH
  4. How to Maximize Laboratory Efficiency and Throughput
    Danlin Wu, Ph.D.
    Senior Director, DMPK
    Roche, Palo Alto, CA
  5. Strategies to Enhance Sensitivity in MS Assays
    Stacy Ho, Ph.D.
    Senior Scientist, DMPK & Pharmaceutics
    Drug and Biomaterial R&D
    Genzyme Corporation, Waltham, MA

Thursday, July 16

Third Plenary Session – Chromatographic Applications to Bioassays

Moderator:

Douglas J. Turk, Ph.D.
NoAb BioDiscoveries Inc.
Mississauga, Ontario, Canada

8:00am

Liquid Chromatography and Affinity-Based Separations in Bioanalysis: An Overview

David S. Hage, Ph.D.
Charles Bessey Professor, Chemistry Department
University of Nebraska, Lincoln, NE

9:00am

Use of Ion Exchange Chromatography in Routine Small Molecule Analysis

Alan Dzerk
Principal Scientist, Department of Bioanalysis
MDS Pharma Services, Lincoln, NE

9:40am

Break

10:20am

Normal Phase and Reverse Phase Methodologies in Support of Lipidomic Assays

Pete J. Stoffolano
Senior Scientist, Bioanalytical Imaging Group
Procter and Gamble Inc., Mason, OH

11:10am

Fast and Two Dimensional Liquid Chromatography

Peter W. Carr, Ph.D.
Professor of Chemistry
University of Minnesota, Minneapolis, MN

12:00pm

Lunch

 

Afternoon Workshop

1:00pm

Open Forum: Dealing with Daily Problems

Russell P. Grant, Ph.D.
Strategic Director NOQS
LabCorp, Burlington, NC

Qin C. Ji, Ph.D.
Senior Principal Scientist, Bioanalytical Science
Bristol-Myers Squibb Company, Princeton , NJ

2:45pm

Tour - Circus World Museum (http://circusworld.wisconsinhistory.org)

Sponsored by:

MPI Research
Mattawan, MI

6:00pm

Dinner

 

Evening Session - Analytical Investigators’ Forum

Moderator

Qin C. Ji, Ph.D.
Senior Principal Scientist, Bioanalytical Science
Bristol-Myers Squibb Company, Princeton , NJ

7:30pm

Applications of UPLC-MS/MS in Bioanalysis

Guowen Liu, Ph.D.
Research Investigator II, Bioanalytical Sciences Department
Bristol-Myers Squibb Company, Princeton, NJ

8:00pm

Improving Digestion Efficiency for MS/MS Quantitation for Large Proteins

Fumin Li, Ph.D.
Staff Scientist, Bioanalytical Chemistry
Covance Laboratories, Madison, WI

8:30

Ligand Binding Assay Specificity: Addressing Issues with Combination Therapies

Kimberly Zinnack, Ph.D.
Senior Associate Scientist, Preclinical & Clinical Development Sciences
BiogenIdec, Cambridge, MA

9:00pm

Wisconsin Cheese Boxes

Sponsored by:

Prevalere Life Sciences, Inc.
A Division of ICON Development Solutions
Whitesboro, NY

Friday, July 17

Fourth Plenary Session – Biosimilar Products: Comparison of Regulatory Standards

Moderator:

Brian P Booth, Ph.D.
Clinical Pharmacologist
Office of Clinical Pharmacology and Biopharmaceutics
Center for Drug Evaluation and Research
Food and Drug Administration, Rockville MD

8:00am

An Overview of Biosimilar Products

Anita M. O'Connor, Ph.D.
Senior Director, Biopharmaceutical Development and Regulatory Services
MDS Pharma Services, Hoffman, NC

8:45am

US Perspective on Biosimilar Products

Marjorie Shapiro, Ph.D.
Chief, Laboratory of Molecular and Developmental Immunology
Division of Monoclonal Antibodies
Center for Drug Evaluation and Research
Food and Drug Administration, Bethesda, MD

9:25am

European Perspective on Biosimilar Products

Robin Thorpe PhD FRCPath
Head, Biotherapeutics Group
National Institute for Biological Standards and Control
Hertfordshire, United Kingdom

10:10am

Panel Discussion

Anita M. O'Connor, Ph.D.
Marjorie Shapiro, Ph.D.
Robin Thorpe PhD FRCPath

10:30am

Adjournment

 

2009 Conference Planning Committee

Lakshmi Amaravadi, Ph.D., BiogenIdec, Cambridge, MA

Mark Arnold, Ph.D., Bristol-Myers Squibb Company, New Brunswick, NJ

Brian P Booth, Ph.D., Food and Drug Administration/CDER, Rockville, MD

Chad Briscoe, MDS Pharma Services, Lincoln, NE

Janice Bush, Pfizer Global Research and Development, New London, CT

Min S. Chang, Ph.D., Biogen Idec, San Diego, CA

Robert Clement, Ph.D., Schering-Plough Research Institute, Lafayette, NJ

Christopher A. Evans, Ph.D.., GlaxoSmithKline, King of Prussia, PA

James E. De Muth, Ph.D., University of Wisconsin, Madison, WI, Conference Director

Eric N. Fluhler, Ph.D., Wyeth Research, Pearl River, NY

Russell P. Grant, Ph.D., LabCorp, Burlington, NC

Michael J. Hayes, Ph.D., Novartis Pharmaceuticals Corporation, East Hanover, NJ, Conference Chair

Stacy Ho, Ph.D., Genzyme Corporation, Waltham, MA

Qin C. Ji, Ph.D., Bristol-Myers Squibb Company, Princeton, NJ

Tom Huggins, Ph.D., Procter and Gamble, Mason, OH

Douglas J. Turk, Ph.D., NoAb BioDiscoveries Inc., Mississauga, Ontario, Canada

Danlin Wu, Ph.D., Roche Palo Alto, Palo Alto, CA

Social Activities

In addition to the educational benefits of this program, the conference is designed to provide registrants with a relaxing environment to meet and share ideas with colleagues with similar interests and network for future collaborative effort. To this end, Devil's Head Resort offers a variety of activities including tennis, indoor and outdoor swimming pools, mountain bikes, nature trails and one of the finest golf courses in Wisconsin. Golf, at a significantly reduced rate, is available to all registrants during Tuesday and Wednesday afternoons of the conference.

Meeting Room

Click here to view photos from 2007

For More Information

James E. De Muth, Ph.D., Conference Director
Extension Services in Pharmacy
777 Highland Avenue
Madison, WI 53705
(608) 262-3130
FAX (608) 262-2431

Send Email

green block